Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Cancer: Principles & Practice of Oncology
  • Language: en
  • Pages: 1494

Cancer: Principles & Practice of Oncology

Announcing the second volume of DeVita, Lawrence and Rosenberg's groundbreaking series, Cancer: Principles & Practice of Oncology—Annual Advances in Oncology. This series of annual volumes focuses on the most significant changes in oncologic research and practice that have taken place during the preceding year. Each volume identifies scientific and clinical areas in oncology that are rapidly changing and show a high potential for affecting the management of cancer patients in the future. These areas may reflect current controversies in oncology and every effort is made to provide clear direction for the practicing oncologist.

Tumor Immunology and Cancer Vaccines
  • Language: en
  • Pages: 388

Tumor Immunology and Cancer Vaccines

- Volume is divided into four sections, allowing easy navagation for researchers and practicing physicians - Text includes clinical trials - Written by leaders in the field

Biological Control Systems and Disease Modelling
  • Language: en
  • Pages: 342

Biological Control Systems and Disease Modelling

None

Immunotherapy of Cancer
  • Language: en
  • Pages: 517

Immunotherapy of Cancer

Expert bench and clinical scientists join forces to concurrently review both the state-of-the-art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cytokines, vaccines, and T-cells, and illustrate their clinical manipulation to combat cancer. Additional chapters address statistical analysis-both of clinical trials and assay evaluations-methods for the discovery of antigens, adoptive T cell therapy, and adaptive and innate immunity. The challenges in clinical trial design, the need for biomarkers of response-such as novel imaging techniques and immunologic monitoring-and the new advances and directions in cancer immunotherapy are also fully examined.

AACR 2019 Proceedings: Abstracts 2749-5314
  • Language: en
  • Pages: 2656

AACR 2019 Proceedings: Abstracts 2749-5314

American Association for Cancer Research 2019 Proceedings: Abstracts 2749-5314 - Part B

AACR 2022 Proceedings: Part B April 11-13
  • Language: en
  • Pages: 3709

AACR 2022 Proceedings: Part B April 11-13

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

AACR 2018 Proceedings: Abstracts 1-3027
  • Language: en
  • Pages: 3143

AACR 2018 Proceedings: Abstracts 1-3027

None

AACR 2022 Proceedings: Part A Online-Only and April 10
  • Language: en
  • Pages: 2293

AACR 2022 Proceedings: Part A Online-Only and April 10

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

Making Sense
  • Language: en
  • Pages: 304

Making Sense

Breast cancer is one of the most commonly diagnosed cancers and a leading cause of death for women worldwide. With advances in molecular engineering in the 1980s, hopes began to rise that a non-toxic and non-invasive treatment for breast cancer could be developed. These hopes were stoked by the researchers, biotech companies, and analysts who worked to make sense of the uncertainties during product development. In Making Sense Sophie Mützel traces this emergence of "innovative breast cancer therapeutics" from the late 1980s up to 2010, through the lens of the narratives of the involved actors. Combining theories of economic and cultural sociology, Mützel shows how stories are integral for ...

AACR 2019 Proceedings: Abstracts 1-2748
  • Language: en
  • Pages: 2881

AACR 2019 Proceedings: Abstracts 1-2748

American Association for Cancer Research 2019 Proceedings: Abstracts 1-2748 - Part A